WEFUN Capsules 825 mg — Class I drug recall D-1180-2023
Terminated recall by Hua Da Trading, Inc. dba Wefun Inc., reported 2023-09-20, distributed nationwide. Marketed Without an Approved NDA/ANDA: FDA analysis found the product to be tainted with sildenafil, an ingred
| Recall number | D-1180-2023 |
|---|---|
| Product type | Drug |
| Classification | Class I |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Hua Da Trading, Inc. dba Wefun Inc., Brooklyn, NY, United States |
| Recall initiated | 2023-08-25 |
| Classified | 2023-09-29 |
| Reported by FDA | 2023-09-20 |
| Terminated | 2026-04-30 |
| Distributed | Nationwide (US) |
| Quantity | 300 cartons |
| Reason classes | unapproved product |
| Lot numbers | 18520168 |
| Expiration dates | 2026-09-30 |
Product
WEFUN Capsules 825 mg, 1x10 blister pack per carton, Manufactured by WEFUN Brooklyn NY 11204 www.eshoponlineusa.com Bar Code X00358V0O5
Reason for recall
Marketed Without an Approved NDA/ANDA: FDA analysis found the product to be tainted with sildenafil, an ingredient found in a FDA approved product for the treatment of male sexual enhancement, making this an unapproved drug.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1180-2023. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.